
CRELD2 as a Prognostic Marker in Triple-Negative Breast Cancer
Could CRELD2 Be a Key Biomarker in Triple-Negative Breast Cancer? A new study from researchers at Necmettin Erbakan University suggests that a specific protein, CRELD2, might help predict outcomes for patients with triple-negative breast cancer […]